1h Free Analyst Time
The genomics market in US is forecasted to grow by USD 6.96 billion during 2023-2028, accelerating at a CAGR of 12.1% during the forecast period. The report on the genomics market in US provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.Speak directly to the analyst to clarify any post sales queries you may have.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by reduction in cost of genetic sequencing, increasing demand for creating and upgrading genome databases, and growing demand for personalized medicine.
The genomics market in US is segmented as below:
By Application
- Diagnostics
- Drug discovery
- Others
By End-user
- Hospitals and clinics
- Academic and research institutes
- Pharmaceutical and biotechnology companies
- Others
By Solution
- Products
- Services
By Geographical Landscape
- North America
The report on the genomics market in US covers the following areas:
- Genomics Market in US sizing
- Genomics Market in US forecast
- Genomics Market in US industry analysis
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
Table of Contents
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation by Application
7 Market Segmentation by End-user
8 Market Segmentation by Solution
9 Customer Landscape
10 Drivers, Challenges, and Opportunity/Restraints
11 Competitive Landscape
12 Competitive Analysis
13 Appendix
List of Exhibits
Executive Summary
The following companies are recognized as the key players in the genomics market in us: Agilent Technologies Inc., BGI Genomics Co. Ltd., Bio Rad Laboratories Inc., Caris Life Sciences, CENTOGENE NV, Color Health Inc., Danaher Corp., Eurofins Scientific SE, F. Hoffmann La Roche Ltd., Illumina Inc., Invitae Corp., LetsGetChecked, Myriad Genetics Inc., Oxford Nanopore Technologies plc, Pacific Biosciences of California Inc., Perkin Elmer Inc., Personalis Inc., QIAGEN N.V., Thermo Fisher Scientific Inc., and Twist Bioscience Corp..Commenting on the report, an analyst from the research team said: "The latest trend gaining momentum in the market is growing adoption of single cell-based genomics analysis."
According to the report, one of the major drivers for this market is the reduction in cost of genetic sequencing.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Agilent Technologies Inc.
- BGI Genomics Co. Ltd.
- Bio Rad Laboratories Inc.
- Caris Life Sciences
- CENTOGENE NV
- Color Health Inc.
- Danaher Corp.
- Eurofins Scientific SE
- F. Hoffmann La Roche Ltd.
- Illumina Inc.
- Invitae Corp.
- LetsGetChecked
- Myriad Genetics Inc.
- Oxford Nanopore Technologies plc
- Pacific Biosciences of California Inc.
- Perkin Elmer Inc.
- Personalis Inc.
- QIAGEN N.V.
- Thermo Fisher Scientific Inc.
- Twist Bioscience Corp.
